Your browser doesn't support javascript.
loading
Cost-effectiveness of infant respiratory syncytial virus preventive interventions in Mali: A modeling study to inform policy and investment decisions.
Laufer, Rachel S; Driscoll, Amanda J; Baral, Ranju; Buchwald, Andrea G; Campbell, James D; Coulibaly, Flanon; Diallo, Fatoumata; Doumbia, Moussa; Galvani, Alison P; Haidara, Fadima C; Kotloff, Karen L; Keita, Adama M; Neuzil, Kathleen M; Orenstein, Evan W; Orenstein, Lauren A V; Pecenka, Clint; Sow, Samba; Tapia, Milagritos D; Ortiz, Justin R; Fitzpatrick, Meagan C.
Afiliação
  • Laufer RS; Center for Vaccine Development & Global Health, 685 W. Baltimore St., University of Maryland School of Medicine, Baltimore, Maryland 21201, USA. Electronic address: rlaufer@som.umaryland.edu.
  • Driscoll AJ; Center for Vaccine Development & Global Health, 685 W. Baltimore St., University of Maryland School of Medicine, Baltimore, Maryland 21201, USA. Electronic address: adriscoll@som.umaryland.edu.
  • Baral R; PATH, 2201 Westlake Avenue, Suite 200, Seattle, Washington 98121, USA. Electronic address: rbaral@path.org.
  • Buchwald AG; Department of Environmental and Occupational Health, Colorado School of Public Health, 13001 East 17th Place Aurora, Colorado 80045, USA. Electronic address: andrea.buchwald@cuanschutz.edu.
  • Campbell JD; Center for Vaccine Development & Global Health, 685 W. Baltimore St., University of Maryland School of Medicine, Baltimore, Maryland 21201, USA. Electronic address: jcampbel@som.umaryland.edu.
  • Coulibaly F; Centre pour le Développement des Vaccins, Ministère de la Santé, BP251 Bamako, Mali. Electronic address: fcoulibaly917@gmail.com.
  • Diallo F; Centre pour le Développement des Vaccins, Ministère de la Santé, BP251 Bamako, Mali. Electronic address: mathusa2005@yahoo.fr.
  • Doumbia M; Centre pour le Développement des Vaccins, Ministère de la Santé, BP251 Bamako, Mali. Electronic address: moisedoum@yahoo.fr.
  • Galvani AP; Center for Infectious Disease Modeling and Analysis, Yale School of Public Health, 135 College St., New Haven, CT 06510, USA. Electronic address: alison.galvani@yale.edu.
  • Haidara FC; Centre pour le Développement des Vaccins, Ministère de la Santé, BP251 Bamako, Mali. Electronic address: fhaidara@cvd-mali.org.
  • Kotloff KL; Center for Vaccine Development & Global Health, 685 W. Baltimore St., University of Maryland School of Medicine, Baltimore, Maryland 21201, USA. Electronic address: kkotloff@som.umaryland.edu.
  • Keita AM; Centre pour le Développement des Vaccins, Ministère de la Santé, BP251 Bamako, Mali. Electronic address: admambyta@gmail.com.
  • Neuzil KM; Center for Vaccine Development & Global Health, 685 W. Baltimore St., University of Maryland School of Medicine, Baltimore, Maryland 21201, USA. Electronic address: kneuzil@som.umaryland.edu.
  • Orenstein EW; Department of Pediatrics, Emory University School of Medicine, 1405 Clifton Rd, Atlanta, Georgia 30322, USA. Electronic address: evan.orenstein@emory.edu.
  • Orenstein LAV; Department of Dermatology, Emory University School of Medicine, 1525 Clifton Rd, Atlanta, Georgia 30322, USA. Electronic address: lauren.orenstein@emory.edu.
  • Pecenka C; PATH, 2201 Westlake Avenue, Suite 200, Seattle, Washington 98121, USA. Electronic address: cpecenka@path.org.
  • Sow S; Centre pour le Développement des Vaccins, Ministère de la Santé, BP251 Bamako, Mali. Electronic address: ssow@som.umaryland.edu.
  • Tapia MD; Center for Vaccine Development & Global Health, 685 W. Baltimore St., University of Maryland School of Medicine, Baltimore, Maryland 21201, USA. Electronic address: mtapia@som.umaryland.edu.
  • Ortiz JR; Center for Vaccine Development & Global Health, 685 W. Baltimore St., University of Maryland School of Medicine, Baltimore, Maryland 21201, USA. Electronic address: jortiz@som.umaryland.edu.
  • Fitzpatrick MC; Center for Vaccine Development & Global Health, 685 W. Baltimore St., University of Maryland School of Medicine, Baltimore, Maryland 21201, USA. Electronic address: meagan.fitzpatrick@som.umaryland.edu.
Vaccine ; 39(35): 5037-5045, 2021 08 16.
Article em En | MEDLINE | ID: mdl-34325934
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Vírus Sincicial Respiratório Humano / Infecções por Vírus Respiratório Sincicial Tipo de estudo: Evaluation_studies / Health_economic_evaluation / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans / Infant País como assunto: Africa Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Vírus Sincicial Respiratório Humano / Infecções por Vírus Respiratório Sincicial Tipo de estudo: Evaluation_studies / Health_economic_evaluation / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans / Infant País como assunto: Africa Idioma: En Ano de publicação: 2021 Tipo de documento: Article